title: PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP.
authors.forename: Richard
authors.initials: R
authors.lastname: Ceska
authors.forename: Tomas
authors.initials: T
authors.lastname: Stulc
authors.forename: Tomas
authors.initials: T
authors.lastname: Zima
authors.forename: Ivan
authors.initials: I
authors.lastname: Malbohan
authors.forename: Lenka
authors.initials: L
authors.lastname: Fialova
mesh_terms: D000069059:Atorvastatin; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis / Q000187:drug effects*; D003327:Coronary Disease / Q000097:blood; D011345:Fenofibrate / Q000494:pharmacology; D006538:Heptanoic Acids / Q000494:pharmacology; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D011266:Pregnancy-Associated Plasma Protein-A / Q000032:analysis / Q000187:drug effects*; D011758:Pyrroles / Q000494:pharmacology
chemical_list: D015415:Biomarkers; D006538:Heptanoic Acids; D000960:Hypolipidemic Agents; D011758:Pyrroles; D002097:C-Reactive Protein; D000069059:Atorvastatin; D011266:Pregnancy-Associated Plasma Protein-A; D011345:Fenofibrate